Journal of Clinical Oncology - ASCO Publications
WEBSep 9, 2024 — A world where cancer is prevented or cured. Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. Through research, education, and promotion of the highest-quality, equitable patient care, ASCO works to conquer cancer and create a world where cancer is …
Evidence-Based Management of Oral Mucositis | JCO Oncology …
WEBFeb 3, 2020 — The morbidity of oral mucositis includes pain, nutritional compromise, and infection risk, which potentially result in breaks or dose reductions in cancer therapy. Historically, management was focused mainly on pain control and nutritional support. However, evidence-based clinical practice guidelines for oral and GI mucositis were …
Nutrition in Cancer Care: A Brief, Practical Guide With a Focus on ...
WEBJan 14, 2021 — Although the diagnostic criteria of malnutrition may differ depending on the tool that is used, the prevalence of malnutrition was reported in several surveys as being up to 50% among hospitalized patients with cancer. 3,8-11 Furthermore, the severity of weight loss is an independent predictive factor for shorter overall survival 5; about 10%-20% of …
Current and Future Management of HER2-Positive Metastatic …
WEBJun 2, 2021 — Advanced breast cancer with overexpression and/or amplification of human epidermal growth factor receptor 2 (HER2) is a clinically aggressive subtype with poor survival outcomes. 1,2 However, with the introduction of trastuzumab, the survival rates have greatly improved. 1 Trastuzumab binds to the extracellular domain IV of HER2 …
Stereotactic Body Radiotherapy for the Management of Early …
WEBFeb 17, 2023 — The standard of care for a patient with medically operable early-stage NSCLC has long been surgical resection. 4 For those patients deemed inoperable because of their high surgical risk, the current standard has emerged over the past 25 years and is now considered to be stereotactic body radiotherapy (SBRT; also known as stereotactic …
Current Management of Appendiceal Neoplasms | American …
WEBMar 25, 2021 — The recently updated 8th edition of the American Joint Committee on Cancer Staging Manual and the 5th edition of the WHO Classification of Digestive System Tumours provide a three-tiered grading system for mucinous appendiceal neoplasms, a unique tumor in situ category for low-grade appendiceal mucinous neoplasms, new descriptions of …
Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update
WEBDec 22, 2021 — An estimated 105,000 new cases of colon cancer were diagnosed in the United States in 2021, 1 of which approximately 39% were localized. 2 Stage II cancers are characterized by a lack of metastatic spread or lymph node involvement, and the main treatment is surgical resection of the primary tumor. Prognosis after resection is …
Management of Cancer Therapy–Associated Oral Mucositis
WEBFeb 3, 2020 — Abstract. Mucositis is a common and feared complication of anticancer therapy that can affect up to 90% of certain populations of patients with cancer. Even seemingly uncomplicated mucositis, which is often self-limited, can result in intense patient discomfort and decline in quality of life. Severe mucositis can be complicated by …
Systemic Treatment of Patients With Metastatic Breast Cancer: …
WEBJan 10, 2024 — In 2024, ASCO published a guideline for clinicians, patients, and policymakers in resource-constrained settings on the treatment of patients with metastatic breast cancer (MBC). 1 The purpose of that guideline is to provide expert guidance on the systemic treatment of MBC to clinicians, public health leaders, patients, and …
ASCO Annual Meeting | ASCO Daily News
WEBJune 19, 2024. Dr. Diwakar Davar and Dr. Jason Luke discuss advances in the neoadjuvant immunotherapy space that were presented at the 2024 ASCO Annual Meeting, including promising outcomes in high-risk melanoma from the NADINA trial, as well as other new treatment options for patients with advanced cancers. Breast Cancer.